Urovant Sciences Ltd
(UROV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | UROV | NMRA | GOSS | ||
| Company | Urovant Sciences Ltd | Neumora Therapeutics Inc | Gossamer Bio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 16.23 | 3.30 | 2.34 | ||
| High | 16.24 | 3.35 | 2.49 | ||
| Low | 16.21 | 3.14 | 2.28 | ||
| Latest | 16.24 | 3.20 | 2.29 | ||
| Change | +0.01 | -0.05 | -0.03 | ||
| % Change | +0.06% | -1.54% | -1.29% | ||
| Volume | 1,739,000 | 3,731,800 | 5,145,700 | ||
| 20-Day Average Volume | 143,510 | 1,640,180 | 5,476,380 | ||
| Previous Close | 16.23 | 3.25 | 2.32 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 16.21 | 2.26 | 2.49 | ||
| 20-Day Raw Stochastic | 87.10% | 83.69% | 15.49% | ||
| 20-Day Relative Strength | 65.56 | 72.56 | 41.39 | ||
| Weighted Alpha | +6.45 | -12.81 | +72.84 | ||
| Today's Opinion | 100% Buy | 88% Buy | 8% Sell | ||
| Previous Opinion | 100% Buy | 88% Buy | 8% Sell | ||
| Last Month's Opinion | 96% Buy | 56% Buy | 32% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 03/19/21 | +50.94% since 02/06/26 | +1.33% since 02/06/26 | ||
| Low | 16.20 on 03/24/21 | 2.09 on 02/09/26 | 2.16 on 02/09/26 | ||
| High | 16.25 on 03/25/21 | 3.46 on 02/12/26 | 2.49 on 02/13/26 | ||
| 1-Month | |||||
| %Chg | +0.43% since 02/26/21 | +49.53% since 01/13/26 | -13.91% since 01/13/26 | ||
| Low | 16.10 on 03/02/21 | 1.84 on 01/20/26 | 2.16 on 02/09/26 | ||
| High | 16.26 on 03/19/21 | 3.46 on 02/12/26 | 3.00 on 01/22/26 | ||
| 3-Month | |||||
| %Chg | +1.25% since 12/24/20 | +18.96% since 11/13/25 | -8.76% since 11/13/25 | ||
| Low | 16.03 on 12/30/20 | 1.50 on 01/06/26 | 2.16 on 02/09/26 | ||
| High | 16.26 on 03/19/21 | 3.46 on 02/12/26 | 3.87 on 12/15/25 | ||
| 6-Month | |||||
| %Chg | +76.14% since 09/25/20 | +105.13% since 08/13/25 | +16.24% since 08/13/25 | ||
| Low | 7.15 on 11/02/20 | 1.42 on 09/17/25 | 1.86 on 08/14/25 | ||
| High | 16.26 on 03/19/21 | 3.46 on 02/12/26 | 3.87 on 12/15/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 531,746 | 534,685 | 530,034 | ||
| Shares Outstanding, K | 32,743 | 167,089 | 231,456 | ||
| Annual Sales | 0 | 0 | 114,700,000 | ||
| Annual Net Income | -146,750,000 | -243,790,000 | -56,530,000 | ||
| Last Quarter Sales | 0 | 0 | 13,290,000 | ||
| Last Quarter Net Income | -46,800,000 | -56,760,000 | -48,220,000 | ||
| 60-Month Beta | 2.35 | 3.20 | 1.93 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.35 on 11/06/25 | -0.21 on 11/05/25 | ||
| Latest Earnings Date | 06/17/21 | 03/02/26 | 03/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||